ADMA Biologics Stock Options


USD 3.36  0.13  4.02%   

ADMA Biologics' option chain provides insight into all available option contracts written on ADMA Biologics' stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of ADMA Biologics' stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given ADMA Biologics option contract. View S&P 500 options
Purchasing ADMA Biologics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" ADMA Biologics calls. Remember, the seller must deliver ADMA Biologics stock to the call owner when a call is exercised.

In The Money vs. Out of Money Option Contracts on ADMA Biologics

Analyzing ADMA Biologics' in-the-money options over time can help investors to take a profitable long position in ADMA Biologics regardless of its overall volatility. This is especially true when ADMA Biologics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money ADMA Biologics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with ADMA Biologics' stock while costing only a fraction of its price.
ADMA Biologics' latest option contracts expiring on 2022-12-16 are carrying combined implied volatility of 140.64 with a put-to-call open interest ratio of 0.07 over 6 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2022-12-16. The current put volume is at 1, with calls trading at the volume of 36. This yields a 0.03 put-to-call volume ratio. The ADMA Biologics option chain provides detailed quote and price information for the current ADMA Biologics option contracts. It shows all of ADMA Biologics' listed puts, calls, expiration dates, strike prices, and other pricing information.

Open Interest Against 2022-12-16 Option Contracts

ADMA Biologics option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in ADMA Biologics' lending market. For example, when ADMA Biologics' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on ADMA Biologics, he or she must hedge the risk by shorting ADMA Biologics stock over its option's life.
The chart above shows ADMA Biologics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. ADMA Biologics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for ADMA Biologics' option, there is no secondary market available for investors to trade.
ADMA Biologics' stock options are financial instruments that give investors the right to buy or sell shares of ADMA Biologics common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell ADMA Biologics stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If ADMA Biologics' stock price goes up or down, the stock options follow.
Please continue to Trending Equities.
Please note that buying 'in-the-money' options on ADMA Biologics lessens the impact of time decay, as they carry both intrinsic and time value. So, even if ADMA Biologics' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money ADMA Biologics contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if ADMA Biologics Stock moves the wrong way.
As of December 3, 2022, Net Income Common Stock is expected to decline to about (73.5 M)

ADMA Biologics Current Options Market Mood

ADMA Biologics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps ADMA Biologics Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of ADMA Biologics' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. ADMA Biologics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current ADMA Biologics' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Rule 16 of the current ADMA Biologics contract

Base on the Rule 16, the options market is currently suggesting that ADMA Biologics will have an average daily up or down price movement of about 8.79% per day over the life of the 2022-12-16 option contract. With ADMA Biologics trading at USD3.36, that is roughly USD0.3. If you think that the market is fully incorporating ADMA Biologics' daily price movement you should consider buying ADMA Biologics options at the current volatility level of 140.64%. But if you have an opposite viewpoint you should avoid it and even consider selling them.

ADMA Biologics Option Chain

When ADMA Biologics' strike price is surpassing the current stock price, the option contract against ADMA Biologics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
ADMA Biologics' option chain is a display of a range of information that helps investors for ways to trade options on ADMA Biologics. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for ADMA Biologics. It also shows strike prices and maturity days for a ADMA Biologics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
DeltaGammaOpen IntExpirationCurrent SpreadLast Price
2022-12-16 CALL at $2.50.86260.20542252022-12-160.8 - 0.950.8In
2022-12-16 PUT at $2.5-0.10480.2043322022-12-160.0 - 0.050.05Out
2022-12-16 PUT at $5.0-0.76260.215602022-12-161.15 - 1.80.0In
2022-12-16 PUT at $7.5-0.96950.053402022-12-164.0 - 4.30.0In

ADMA Biologics Net Income Common Stock Over Time

The amount of net income (loss) for the period due to common shareholders. Typically differs from Net Income to the parent entity due to the deduction of Preferred Dividends.
   Net Income Common Stock   

ADMA Biologics Historical Liabilities

While analyzing the current debt level is an essential aspect of forecasting the current year budgeting needs of ADMA Biologics, understanding its historical liability is critical in projecting ADMA Biologics' future earnings, especially during periods of low and high inflation and deflation. Many analysts look at the trend in assets and liabilities and evaluate how ADMA Biologics uses its financing power over time.

ADMA Biologics Investors Sentiment

The influence of ADMA Biologics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in ADMA Biologics. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to ADMA Biologics' public news can be used to forecast risks associated with investment in ADMA Biologics. The trend in average sentiment can be used to explain how an investor holding ADMA Biologics can time the market purely based on public headlines and social activities around ADMA Biologics. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
ADMA Biologics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for ADMA Biologics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average ADMA Biologics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on ADMA Biologics.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ADMA Biologics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ADMA Biologics' short interest history, or implied volatility extrapolated from ADMA Biologics options trading.

Pair Trading with ADMA Biologics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ADMA Biologics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ADMA Biologics will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to ADMA Biologics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ADMA Biologics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ADMA Biologics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ADMA Biologics to buy it.
The correlation of ADMA Biologics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ADMA Biologics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ADMA Biologics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ADMA Biologics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to Trending Equities. You can also try Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Complementary Tools for analysis

When running ADMA Biologics price analysis, check to measure ADMA Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADMA Biologics is operating at the current time. Most of ADMA Biologics' value examination focuses on studying past and present price action to predict the probability of ADMA Biologics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ADMA Biologics' price. Additionally, you may evaluate how the addition of ADMA Biologics to your portfolios can decrease your overall portfolio volatility.
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Is ADMA Biologics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ADMA Biologics. If investors know ADMA Biologics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ADMA Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
661.2 M
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of ADMA Biologics is measured differently than its book value, which is the value of ADMA Biologics that is recorded on the company's balance sheet. Investors also form their own opinion of ADMA Biologics' value that differs from its market value or its book value, called intrinsic value, which is ADMA Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ADMA Biologics' market value can be influenced by many factors that don't directly affect ADMA Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ADMA Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine ADMA Biologics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ADMA Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.